- ASSISTANT PROFESSOR | Neurosurgery
- Hospital Affiliations
- The Mount Sinai Hospital
- Mount Sinai Beth Israel
- Mount Sinai St. Luke's and Mount Sinai West
Christopher Kellner, MD is an Assistant Professor in Neurosurgery specializing in the endovascular and minimally invasive treatment of different forms of stroke, aneurysms, arteriovenous malformations, dural arteriovenous fistulas, cavernous malformations, and other vascular problems of the brain and spine. He is Director of the Intracerebral Hemorrhage Program and Principal Investigator of the Cerebrovascular Translational Laboratory.
Dr. Kellner received his undergraduate degree from Harvard University and earned his medical degree from the College of Physicians and Surgeons at Columbia University. He also completed his neurosurgery residency training at New York Presbyterian - Columbia University. He then performed his endovascular fellowship at Mount Sinai with Drs. Alejandro Berenstein, J Mocco, Johanna Fifi, and Reade DeLeacy.
Dr. Kellner has authored over 60 peer-reviewed publications and 10 book chapters. His research focuses on improving outcomes in endoscopic minimally invasive intracerebral hemorrhage evacuation, decreasing brain inflammation after stroke, early diagnosis of stroke, and early diagnosis of cerebral aneurysms. He is the principal investigator of the VITAL study, a multicenter clinical trial evaluating the VIPS device, which is a non-invasive, portable, easy to use severe stroke detection device that can be used in the ambulance to correctly diagnose severe stroke to triage patients to the right hospital.
Dr. Kellner believes that the patient-doctor relationship is built on a foundation of understanding that comes from education, trust, and accessibility. He uses 3D models and virtual reality when possible to describe complex procedures to his patients. He also uses these technologies to rehearse a surgery prior to the real thing.
- 3D Simulation
- Aneurysm Coiling
- Arteriovenous Malformation of the Brain
- Balloon Test Occlusion
- Brain Aneurysm
- Carotid Artery Stenosis
- Carotid Stenting
- Cavernous Malformations
- Cerebral Abscess
- Cerebral Vasospasm
- Cerebrospinal Fluid Leak
- Computer Guided Crainiotomy
- Developmental Venous
- Dural Arteriovenous Fistula (DAVF)
- Endovascular Embolization
- Facial Arteriovenous Malformations
- Facial Vascular Malformations
- Intracerebral Hemorrhage (ICH)
- Intracranial Stenting
- Mechanical Thrombectomy
- Microvascular Clipping
- Microvascular Occlusion
- Neurocritical Care
- Spinal Vascular Malformations
- Stereotactic Radiosurgery
- Subarachnoid Hemorrhage
- Subdural Hematoma
- Vascular Malformations
- Venous Sampling
- Venous Sinus Thrombosis
- Ventriculoperitoneal Shunt
Regeneration, Rehabilitation, Stem Cells, Stroke
MD, Columbia University College of Physicians & Surgeons
Columbia-Presbyterian Medical Center
Fellowship, Endovascular Intervention/Peripheral
Mount Sinai Hospital
WIN: Multicenter Registry of Ruptured, Wide-Neck, Anterior Circulation Aneurysms
Subarachnoid hemorrhage due to rupture of an intracranial aneurysm has a high rate of morbidity and mortality. For many years, there has been controversy around the preferred method of treatment. Both open surgical aneurysm clipping and endovascular aneurysm coiling are the two g...
VITAL Phase II: Volumetric Integral Phase-shift Spectroscopy (VIPS) for the Noninvasive Detection of Hemispheric Bioimpedance Asymmetry in Severe Brain Pathology
The purpose of this two-part study is to assess the ability of the Fluids Monitor to detect hemispheric bioimpedance asymmetry associated with acute brain pathology in patients presenting with suspected Acute Ischemic Stroke (AIS). The second phase, algorithm validation, will enr...
NYC MIST: Reducing Disparities in Mechanical Embolectomy Access for Patients of New York City Via a Mobile Intervetional Stroke Team: Systems of Care and Time-To-Treatment
The purpose of this study is to determine how different methods of interventional service delivery, specifically a mobile interventional stroke team, affect outcomes in the Mount Sinai Health System. The primary endpoint is to record time between first hospital arrival and final ...
PAIKEA: Perihematomal Edema in ICH Expression Analysis
Intracerebral hemorrhage (ICH) accounts for 10% of all strokes and the current surgical treatment and therapies are limited. In 2001, Hemphill III et al. developed the ICH Score, which allowed for a standardization of clinical treatment and research. Recently, a few new clinical ...
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Kellner has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.